J. Vose

发表

Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients.

P. Bierman, J. Talmadge, K. Ino, 2000, Experimental hematology.

Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products

J. Talmadge, J. Vose, M. Varney, 1999, Bone Marrow Transplantation.

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies

M. Bishop, J. Armitage, A. Kessinger, 1998, Bone Marrow Transplantation.

Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow

J. Vose, J. Talmadge, A. Kessinger, 1997, Bone Marrow Transplantation.

Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor.

P. Bierman, J. Jackson, M. Bishop, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection of Minimal Residual Disease in Hematopoietic Tissues a

T. Greiner, J. Vose, W. Sanger, 1995 .

Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia

M. Bishop, J. Armitage, A. Kessinger, 2000, Bone Marrow Transplantation.

A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation.

J. Armitage, P. Bierman, J. Vose, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization.

J. Armitage, M. Tempero, M. Bishop, 1995, Journal of hematotherapy.

Epstein–Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases

R. Bashir, B. Smir, J. Vose, 1998, Bone Marrow Transplantation.

Myelodysplastic syndrome after autologous transplant for lymphoma.

A. Kessinger, J. Anderson, J. Vose, 1994, Blood.

Detection of Minimal Residual Disease in Hematopoietic Tissues a

T. Greiner, W. Sanger, J. Sharp, 1995, Annals of the New York Academy of Sciences.

Therapeutic uses of MAbs directed against CD20.

J. Vose, 2000, Cytotherapy.

Comparison of two methods of bone marrow processing for autologous bone marrow transplantation.

J. Jackson, J. Armitage, A. Kessinger, 1992, Progress in clinical and biological research.

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)

J. Armitage, R. Herzig, A. Bashey, 2001, Bone Marrow Transplantation.

The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma.

D. Weisenburger, J. Armitage, P. Bierman, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin’s lymphoma: results from the University of Nebraska Medical Center 1989 to 1995

M. Bishop, J. Armitage, A. Kessinger, 1999, Bone Marrow Transplantation.

Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin’s lymphoma and multiple myeloma: results from the expanded access program

P. Mcsweeney, S. Devine, D. Johns, 2013, Bone Marrow Transplantation.

Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members.

M. Tempero, J. Siegel, D. Colcher, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial.

J. Armitage, P. Bierman, J. Vose, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.

J. Armitage, J. Vose, J. Klein, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.

W. Chan, P. Bierman, J. Vose, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents.

D. Weisenburger, J. Armitage, P. Bierman, 1992, Blood.

M Ab Therapy: the use of Anti-CD20 Abs Therapeutic uses of MAbs directed against CD20

J. Vose, J. Vose, 2000 .

High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft

J. Armitage, P. Bierman, J. Vose, 1994 .

Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignancies.

P. Bierman, J. Vose, D. Neuberg, 1993, Blood.